p>"The criteria that companies look for when selecting a viable AED program include a comprehensive training solution, exceptional lifesaving technology, best-in-class reliability, product durability, and ease of use for their employees," said Marc Lawrence, HeartSine senior vice president. "The HeartSine samaritan PAD exceeds these criteria with the highest clinical standards backed by years of research and innovation. Our superior technology, 10-year warranty and 4-year Pad Pak™ life provides our clients with the power to save a life, at the lowest overall cost of ownership."
Shock for Life, a channel partner of HeartSine products and an American Heart Association authorized training center, is responsible for installation of the AED devices in Wegmans stores and for training employees on how to use the HeartSine 300P PAD to administer lifesaving treatment.
"Our nationally standardized training program follows American Heart Association guidelines," said MaryBeth Barber, RN, BSN, CEO, Shock for Life. "For the Wegmans implementation, we'll be conducting 'Hands On' CPR/AED training in all of their stores, teaching employees how to recognize and care for breathing and cardiac emergencies, and how to use the HeartSine defibrillator for treatment."
Wegmans stores are located in New York, Pennsylvania, New Jersey, Virginia, and Maryland. Its first New England store will open in Northborough, Massachusetts in October 2011. The family-owned company, founded in 1916, is recognized as an industry leader and innovator. Wegmans has been named one of the '100 Best Companies to Work For' by FORTUNE magazine for fourteen consecutive years. In 2011, Wegmans ranked #3 on the list.
About HeartSine Technologies
A world leader in personal and public access defibrillators, HeartSine's mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care. HeartSine
Page: 1 2 3 Related medicine technology :1
|SOURCE HeartSine Technologies, Inc.|
Copyright©2010 PR Newswire.
All rights reserved
. Sangart Initiates Phase 2b Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock2
. US Patent Granted for a New Family of Heat Shock Protein 90 (Hsp90) Inhibitors for the Treatment of Cancer and Neurodegenerative Indications3
. Tulsa Shock Guard Andrea Riley and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health4
. Shockwave System Developed to Aid Concussion Detection5
. Sepsis and Septic Shock on the Rise, Affecting Younger Patients6
. Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock7
. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference8
. HeartSine® Technologies Donates Lifesaving AED to Camphill Special School9
. HeartSine® Increases AED System Warranty to Longest in the Industry10
. ChemOutsourcing Announces the 62 Exhibitors to Present API & New Chemical Technologies at September 12-15, 2011 Show in NJ11
. VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies